BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36645206)

  • 1. Recurrent high-grade astrocytoma with somatic mosaicism of isocitrate dehydrogenase gene mutation.
    Masui K; Onizuka H; Nitta M; Muragaki Y; Kawamata T; Komori T
    Pathol Int; 2023 Mar; 73(3):144-146. PubMed ID: 36645206
    [No Abstract]   [Full Text] [Related]  

  • 2. [Astrocytoma with 1p19q codeletion].
    Ryzhova MV; Galstyan SA; Shishkina LV; Panina TN; Voronina EI; Telysheva EN; Kotelnikova AO; Starovoitov DV; Shaikhaev EG; Snigireva GP; Sycheva RV; Kadyrov SU; Adaev AR; Pitskhelauri DI; Kudieva ES; Zheludkova OG; Golanov AV
    Arkh Patol; 2023; 85(1):51-56. PubMed ID: 36785962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
    Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
    J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma.
    Schittenhelm J; Mittelbronn M; Meyermann R; Melms A; Tatagiba M; Capper D
    Acta Neuropathol; 2011 Nov; 122(5):651-2. PubMed ID: 21983902
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma].
    Pan Y; Qi XL; Wang LM; Dong RF; Zhang M; Zheng DF; Chang Q; Zhong YF
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):292-8. PubMed ID: 24004584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma.
    Masui K; Onizuka H; Muragaki Y; Kawamata T; Kurata A; Komori T
    Brain Tumor Pathol; 2024 Apr; 41(2):92-95. PubMed ID: 38597998
    [No Abstract]   [Full Text] [Related]  

  • 7. In response: IDH1 mutation expression is associated with seizures and protoplasmic subtype in patients with low-grade glioma.
    Morokoff A; Liubinas S
    Epilepsia; 2014 Oct; 55(10):1679-80. PubMed ID: 25330902
    [No Abstract]   [Full Text] [Related]  

  • 8. Diffuse glioma - Rare homozygous IDH point mutation, is it an oncogenetic mechanism?
    Singh A; Gurav M; Dhanavade S; Shetty O; Epari S
    Neuropathology; 2017 Dec; 37(6):582-585. PubMed ID: 28782849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.
    Auer TA; Kern M; Fehrenbach U; Tanyldizi Y; Misch M; Wiener E
    Neuroradiol J; 2021 Oct; 34(5):392-400. PubMed ID: 33573473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MET fusions and splicing variants is a strong adverse prognostic factor in astrocytoma, isocitrate dehydrogenase mutant.
    Liu L; Zhang KN; Zhao Z; Li G; Chai RC; Li Z; Liu X; Chen J; Jiang T
    Brain Pathol; 2024 May; 34(3):e13198. PubMed ID: 37530224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: report of a secondary anaplastic astrocytoma carrying the IDH1 mutation.
    Mascelli S; Raso A; Biassoni R; Severino M; Sak K; Joost K; Milanaccio C; Barra S; Grillo-Ruggieri F; Vanni I; Consales A; Cama A; Capra V; Nozza P; Garrè ML
    J Neurooncol; 2012 Sep; 109(3):477-84. PubMed ID: 22821382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of gliomas in patients with somatic IDH mosaicism.
    Bonnet C; Thomas L; Psimaras D; Bielle F; Vauléon E; Loiseau H; Cartalat-Carel S; Meyronet D; Dehais C; Honnorat J; Sanson M; Ducray F
    Acta Neuropathol Commun; 2016 Mar; 4():31. PubMed ID: 27036230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas.
    Zhang Z; Chan AK; Ding X; Li Y; Zhang R; Chen L; Liu Y; Wang Y; Xiong J; Ng HK; Yao Y; Zhou L
    Neuro Oncol; 2017 Jul; 19(7):1008-1010. PubMed ID: 28874004
    [No Abstract]   [Full Text] [Related]  

  • 14. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas.
    Marucci G
    Epilepsia; 2014 Oct; 55(10):1678-9. PubMed ID: 25330901
    [No Abstract]   [Full Text] [Related]  

  • 16. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
    Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
    Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic significance of combined TERT and IDH gene mutation analysis in diffusely infiltrating gliomas].
    Liu QQ; Yin XX; Zou Y; Yu TP; Gong J; Chen XQ; Nie L; Xu M; Zhang MN; Zhou Q; Chen N
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):658-663. PubMed ID: 30220117
    [No Abstract]   [Full Text] [Related]  

  • 18. Finding of IDH1 R132H mutation in histologically non-neoplastic glial tissue changes surgical strategies, a case report.
    Søndergaard CB; Scheie D; Sehested AM; Skjøth-Rasmussen J
    Childs Nerv Syst; 2017 Jul; 33(7):1217-1220. PubMed ID: 28236063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data.
    Kim N; Kim SH; Kang SG; Moon JH; Cho J; Suh CO; In Yoon H; Chang JH
    Radiat Oncol; 2020 Jul; 15(1):184. PubMed ID: 32736562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.
    Çelik S; Öven BB; Demir MK; Yılmaz EÇ; Kanan D; Özdamarlar U; Emirzeoglu L; Yapıcıer Ö; Kılıç T
    Clin Neurol Neurosurg; 2021 Aug; 207():106745. PubMed ID: 34146841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.